Page 9 - Flipbook
P. 9
Prostate Cancer Nomenclature
Early advanced
disease: mCSPC
Metastatic, castration-
Locally advanced / sensitive prostate cancer Late advanced
Localised disease
regional disease disease: mCRPC
Predominantly Cancer has spread to local Early advanced Metastatic, castration-
adenocarcinomas lymph nodes or other disease: nmCRPC resistant prostate cancer
nearby tissue
Treatment is based May require multiple
on risk stratification Also known as rising Non-metastatic, castration- lines of therapy
(Very low to very high) PSA non-castrate resistant prostate cancer
m, metastatic; nm, non-metastatic; CSPC, castration sensitive prostate cancer; CRPC, castration resistant prostate cancer; PSA, prostate specific antigen
Scher HI et al. J Clin Oncol 2016;34:1402-18.
